StockSelector.com
  Research, Select, & Monitor Thursday, April 19, 2018 7:47:06 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Ironwood Pharmaceuticals, Inc.$17.60($.04)(.23%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Ironwood Pharmaceuticals, Inc. has an overall rank of 6376 out of 6928 stocks based on 7 positive rankings and 10 negative rankings.

Positive Rankings
PEGValue
Ironwood Pharmaceuticals has a PEG Value of $236.25. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 1,242.33% in the next year. Among companies with a PEG Value above the current stock price, Ironwood Pharmaceuticals is ranked 37.
SSValue
The StockSelector Value for Ironwood Pharmaceuticals is $238.47. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Ironwood Pharmaceuticals is ranked 115.
Estimated Revenue Growth
Ironwood Pharmaceuticals rank is 247
10 Day Gain
Ironwood Pharmaceuticals rank is 272
Up EPS Surprise
Ironwood Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings.
Historic Revenue Growth
Ironwood Pharmaceuticals rank is 932
90 Day Gain
Ironwood Pharmaceuticals rank is 1022
Negative Rankings
Price-to-Book
Ironwood Pharmaceuticals rank is 17
Debt-to-Equity
Ironwood Pharmaceuticals rank is 22
Negative ROE
Ironwood Pharmaceuticals rank is 24
High vPut/Call
Ironwood Pharmaceuticals has a high Put/Call ratio of 3.48 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ironwood Pharmaceuticals is ranked 288.
Overbought Stochastics
Ironwood Pharmaceuticals rank is 366
High Put/Call
Ironwood Pharmaceuticals has a high Put/Call ratio of 1.23 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ironwood Pharmaceuticals is ranked 532.
Price-to-Sales
Ironwood Pharmaceuticals rank is 556
Negative Net Margin
Ironwood Pharmaceuticals rank is 596
Negative ROA
Ironwood Pharmaceuticals rank is 829
Negative Cash Growth
Ironwood Pharmaceuticals rank is 1206







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.